Dr. Robert Malenka: How Your Brain’s Reward Circuits Drive Your Choices | Huberman Lab Podcast

Caution

Robert Malenka emphasizes the importance of a cautious approach to psychedelic research. He shares personal experiences with bad trips and the potential risks involved, stressing the need for rigorous, ethical studies. Andrew Huberman agrees, noting the excitement around psychedelic research but also the necessity for careful, controlled trials 1. Malenka supports studies on substances like Ibogaine, provided they are conducted thoughtfully and ethically 2.

I do worry that if some people take these substances and bad things happen, it will slow down the excitement that's currently happening.

--- Robert Malenka

   

MDMA

MDMA's unique effects on serotonin and dopamine systems make it a fascinating subject for research. Robert Malenka explains how MDMA causes serotonin and dopamine to be released, leading to its distinctive effects compared to other stimulants 3. He also discusses the potential of MDMA in treating social anxiety and its impact on social behaviors, particularly in the context of autism spectrum disorders 4.

MDMA affects the serotonin system more than the dopamine system, which is why it provides a different experience than other amphetamines.

--- Robert Malenka

   

Therapeutics

The therapeutic potential of psychedelics is vast but requires careful exploration. Robert Malenka highlights the need for ethical research to understand the benefits and risks of these substances 1. He discusses how drugs of abuse cause significant changes in the brain's reward circuitry, which can be harnessed for therapeutic purposes 5.

These drugs are tricking the reward circuitry to say this stimulus, this experience is really important for my survival.

--- Robert Malenka